Pregled bibliografske jedinice broj: 1188999
Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease—A cross-sectional study
Association of chronic inflammation with cardiovascular risk in chronic obstructive pulmonary disease—A cross-sectional study // Health Science Reports, 5 (2022), 3; 1-19 doi:10.1002/hsr2.586 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1188999 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Association of chronic inflammation with
cardiovascular risk in chronic obstructive
pulmonary disease—A cross-sectional study
Autori
Ljubičić, Đivo ; Balta, Vedran ; Dilber, Dario ; Vražić, Hrvoje ; Đikić, Domagoj ; Odeh, Dyana ; Čerkez Habek, Jasna ; Lozo Vukovac, Emilija ; Tudorić, Neven
Izvornik
Health Science Reports (2398-8835) 5
(2022), 3;
1-19
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
arterial stiffness, biological systems inflammatory markers, cardiovascular risk, COPD, lungfunction
Sažetak
Background and Aims COPD is progressive lung disease with known higher cardiovascular (CV) risk, mainly attributed to smoking of cigarettes as the main etiological factor of disease. The aim of this study was to compare CV risk in patients with COPD to control groups of smokers and non- COPD and to investigate the relation of lung function variables, COPD severity, and smoking with Systemic Coronary Risk Estimation (SCORE) risk calculation, arterial stiffness (AS) values, and biological systemic inflammatory markers. Methods A total of 208 subjects were included in this study: 61 subjects diagnosed with COPD, 83 smokers without COPD, and 64 nonsmokers without COPD. Medical history and clinical data were recorded, including assessment of pulmonary function and AS, calculation of ankle-brachial index, blood analysis, and CV risk assessment by SCORE risk calculation. Results Subjects with COPD had significantly higher values of SCORE calculation of risk, central aortic pressure, AS, and markers of systemic inflammation compared to control groups of smokers and nonsmokers without COPD (p < 0.001). Furthermore, statistically significant increase in hs-CRP concentration was found between the COPD group and the control group of non-COPD smokers (p < 0.001), and a statistically significantly higher SCORE calculation was found in the COPD group compared to control groups of smokers and nonsmokers without COPD (p < 0.001). Conclusion The results of the research support further identification and research of biological markers and simple specific tests such as arteriography that will enable progress in personalized treatment of patients with COPD and better primary and secondary prevention of comorbidities with the aim of improved treatment outcome.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti, Javno zdravstvo i zdravstvena zaštita
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split,
Hrvatsko katoličko sveučilište, Zagreb
Profili:
Emilija Lozo Vukovac
(autor)
Vedran Balta
(autor)
Dyana Odeh
(autor)
Domagoj Đikić
(autor)
Hrvoje Vražić
(autor)
Jasna Čerkez Habek
(autor)
Neven Tudorić
(autor)
Dario Dilber
(autor)
Đivo Ljubičić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Scopus